Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-25-220480
Filing Date
2025-09-26
Accepted
2025-09-26 16:10:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 31204
2 EX-99.1 ck0000000000-ex99_1.pdf EX-99.1 94893
3 EX-99.2 ck0000000000-ex99_2.pdf EX-99.2 97695
  Complete submission text file 0001193125-25-220480.txt   298854
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Semnur, Inc. (Subject) CIK: 0001584541 (see all company filings)

EIN.: 462968523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-95243 | Film No.: 251350530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filed by) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)